arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Incyte Corporation

INCY Health Care Biotechnology: Commercial Physical & Biological Resarch
$116.93
▲ +0.3% Today
as of Oct 22, 16:49 ET
Last 30 days -4.30% Sep 14 → Oct 22
$107.10 $112.61 $118.12 $123.63 $129.14 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$113.93
High
$117.17
Low
$112.76
Volume
$2M
Avg Vol
$2M
Mkt Cap
$23.0B
P/E (TTM)
20.12
Beta
—
52w High
$132.60
52w Low
$84.02
Div Yield
—
Shares Out
$200M

Recent Press Releases & News last 60 days · 25 items

Oct 23 · 03:02 MarketBeat
Prelude Therapeutics Spotlights JAK2, KAT6A Programs and Potential $100M Incyte Option
Oct 22 · 13:00 Zacks
Analysts Estimate Incyte (INCY) to Report a Decline in Earnings: What to Look Out for
Oct 22 · 11:09 MT Newswires
Leerink Partners Adjusts Price Target on Incyte to $154 From $155
▸ Show all 25 press releases & news Free account →

INCY earnings at a glance

Incyte Corporation (INCY) is scheduled to report earnings on Tuesday, October 27, 2026 — in 4 days. Analysts expect earnings per share of -$3.87, compared with $2.03 in the same quarter last year (-291%). The options market is pricing a move of about ±5.0% after the report, a range of roughly $111.12 to $122.74 from today's $116.93. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±5.5% on average; after the most recent report on Jul 28, 2026 it moved +9.3%. That means options currently expect about the same movement than INCY has typically delivered. INCY beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 42%. The share price of $116.93 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$84
$133
68% of range
Avg surprise (last 6)
+28.5%
Avg reaction (last 6)
+2.2%
67% positive
Latest IV / EM
42%
EM ±5.0% · $115 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.04$-0.83$0.38$1.59$2.80 Actual $0.10Actual $0.90Actual $0.76Actual $0.75Actual $-2.04Actual $0.54Actual $0.89Est $0.75Actual $1.31Est $1.14Actual $2.03Est $1.38Actual $1.56Est $1.64Actual $1.55Est $1.14Actual $2.80Est $1.76 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-445M$25M$495M$965M$1.4B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jul 28, 2026Jun/2026 $2.80 $1.76 +59.1% +34.4% +9.3% earnings
Tue Apr 28, 20268K 2026-04-28 $1.55 $1.14 +36.0% — +2.1% earnings
Tue Feb 10, 20268K 2026-02-10 $1.56 $1.64 -4.9% — -8.2% earnings
Tue Oct 28, 2025Sep/2025 $2.03 $1.38 +47.1% — -1.5% earnings
Tue Jul 29, 2025Jun/2025 $1.31 $1.14 +14.9% — +10.3% earnings
Tue Apr 29, 2025Mar/2025 $0.89 $0.75 +18.7% — +1.5% earnings
Mon Sep 30, 2024Sep 2024 $0.54 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.04 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.75 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.76 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.90 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.10 — — — — financials
Fri Sep 30, 2022Sep 2022 $0.50 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Oct 27, 2026Sep/2026OTHER -$3.87$2.03 -290.6%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$1.27B—$1.37B$1.22B$1.05B—$1.14B$1.04B
Cost of revenue$105M—$99M$79M$73M—$86M$77M
Gross profit————————
Operating income$301M—$444M$530M$205M—$146M$-478M
Net income$303M—$424M$405M$158M—$106M$-445M
EPS (diluted)$1.47—$2.11$2.04$0.80—$0.54$-2.04

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$3.46B$3.10B$2.46B$1.95B$1.94B$1.69B$1.30B$987M
Inventory$116M$101M$83M$83M$64M$59M$70M$101M
Total current assets$5.48B$5.02B$4.28B$3.64B$3.51B$3.24B$2.81B$2.57B
Total assets$7.34B$6.96B$6.33B$5.82B$5.75B$5.44B$5.01B$4.66B
Long-term debt————————
Total liabilities$1.72B$1.79B$1.68B$1.65B$2.08B$2.00B$1.84B$1.66B
Total equity$5.62B$5.17B$4.65B$4.17B$3.67B$3.45B$3.17B$3.00B

Implied volatility — last 90 days

27%43%59%76%92% Jun 07 — IV 56% · EM ±7.8%Jun 08 — IV 53% · EM ±7.0%Jun 09 — IV 52% · EM ±6.5%Jun 10 — IV 57% · EM ±6.8%Jun 11 — IV 49% · EM ±5.4%Jun 12 — IV 40% · EM ±4.1%Jun 15 — IV 47% · EM ±3.4%Jun 16 — IV 54% · EM ±3.2%Jun 17 — IV 56% · EM ±2.3%Jun 19 — IV 28% · EM ±6.1%Jun 22 — IV 35% · EM ±7.4%Jun 23 — IV 28% · EM ±5.7%Jun 24 — IV 30% · EM ±6.0%Jun 25 — IV 30% · EM ±5.9%Jun 26 — IV 36% · EM ±6.9%Jun 29 — IV 33% · EM ±5.8%Jun 30 — IV 29% · EM ±5.1%Jul 01 — IV 33% · EM ±5.6%Jul 02 — IV 35% · EM ±5.6%Jul 03 — IV 36% · EM ±5.6%Jul 06 — IV 38% · EM ±5.3%Jul 07 — IV 35% · EM ±4.6%Jul 08 — IV 42% · EM ±5.2%Jul 09 — IV 36% · EM ±4.2%Jul 10 — IV 39% · EM ±4.3%Jul 13 — IV 40% · EM ±3.3%Jul 14 — IV 34% · EM ±2.5%Jul 15 — IV 53% · EM ±3.1%Jul 16 — IV 75% · EM ±3.1%Jul 20 — IV 37% · EM ±8.7%Jul 21 — IV 39% · EM ±9.2%Jul 22 — IV 36% · EM ±8.3%Jul 23 — IV 40% · EM ±9.0%Jul 24 — IV 39% · EM ±8.6%Jul 27 — IV 41% · EM ±8.7%Jul 28 — IV 36% · EM ±7.4%Jul 29 — IV 34% · EM ±6.8%Jul 30 — IV 33% · EM ±6.5%Jul 31 — IV 33% · EM ±6.4%Aug 03 — IV 30% · EM ±5.4%Aug 04 — IV 33% · EM ±5.7%Aug 05 — IV 35% · EM ±5.9%Aug 06 — IV 42% · EM ±6.8%Aug 07 — IV 39% · EM ±6.0%Aug 10 — IV 34% · EM ±4.7%Aug 11 — IV 36% · EM ±4.7%Aug 12 — IV 37% · EM ±4.6%Aug 13 — IV 33% · EM ±3.9%Aug 14 — IV 40% · EM ±4.5%Aug 17 — IV 43% · EM ±3.6%Aug 18 — IV 33% · EM ±2.4%Aug 19 — IV 38% · EM ±2.3%Aug 20 — IV 92% · EM ±3.9%Aug 24 — IV 37% · EM ±7.7%Aug 25 — IV 31% · EM ±6.3%Aug 26 — IV 31% · EM ±6.2%Aug 27 — IV 36% · EM ±7.1%Aug 28 — IV 35% · EM ±6.7%Aug 31 — IV 38% · EM ±6.8%Sep 01 — IV 32% · EM ±5.5%Sep 02 — IV 36% · EM ±6.0%Sep 03 — IV 38% · EM ±6.2%Sep 04 — IV 34% · EM ±5.2%Sep 07 — IV 38% · EM ±5.2%Sep 08 — IV 39% · EM ±5.1%Sep 09 — IV 40% · EM ±5.0%Sep 10 — IV 36% · EM ±4.2%Sep 11 — IV 37% · EM ±4.0%Sep 14 — IV 50% · EM ±4.2%Sep 15 — IV 61% · EM ±4.4%Sep 16 — IV 41% · EM ±2.4%Sep 17 — IV 76% · EM ±3.2%Sep 21 — IV 33% · EM ±6.8%Sep 22 — IV 41% · EM ±8.4%Sep 23 — IV 39% · EM ±7.8%Sep 24 — IV 35% · EM ±6.9%Sep 25 — IV 42% · EM ±8.1%Sep 28 — IV 41% · EM ±7.2%Sep 29 — IV 39% · EM ±6.7%Sep 30 — IV 38% · EM ±6.4%Oct 01 — IV 48% · EM ±7.8%Oct 02 — IV 41% · EM ±6.5%Oct 06 — IV 52% · EM ±6.9%Oct 07 — IV 45% · EM ±5.6%Oct 08 — IV 42% · EM ±5.0%

Sector peers

MEDP
Medpace Holdings, Inc.
$16.9B $653.96+5.1%
CRL
Charles River Laboratories International, Inc.
$14.3B $339.66+7.7%
ICLR
ICON plc
$12.6B $185.43+6.5%
IQV
IQVIA Holdings, Inc.
$42.5B $278.32+3.9%
ABSI
Absci Corporation
$1.8B $9.37+3.3%
OABI
OmniAb, Inc.
$663M $4.78-3.6%

INCY earnings FAQ

When is INCY's next earnings date?

Incyte Corporation is expected to report on October 27, 2026.

What is INCY's expected move for earnings?

Options currently price a move of about ±5.0%, or $5.81 per share either way from $116.93.

How does INCY stock usually react to earnings?

Across the last 6 reports the average next-day move was ±5.5%, up 4 times and down 2 times.

What EPS are analysts expecting from Incyte Corporation?

The consensus estimate is -$3.87 per share, versus $2.03 a year ago.

What is INCY's implied volatility?

INCY's at-the-money implied volatility is about 42% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in